Global hiv vaccine enterprise

Global HIV Vaccine Enterprise


  • Organization TypeIndependent/None, Advocacy NGO, Association
  • Staff6-25
  • HeadquartersUnited States
  • Founded2003
The Global HIV Vaccine Enterprise is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine through: A shared Scientific Strategic Plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery to development and access Increased resources: Mobilizing significant new funding to achieve the Scientific Strategic Plan and grow the field of HIV vaccine research and development Greater collaboration: In keeping with the intent of the Scientific Strategic Plan, promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts  History Soon after HIV was identified as the cause of AIDS in 1983, there was an expectation that an effective vaccine would be tested, developed and deployed within several years. The intense research effort conducted during the last 20 years has produced important information on the virus and the disease, but an effective vaccine remains elusive. To confront this challenge, in June 2003, a group of 24 leaders in the field of HIV vaccines published a Policy Forum article in the journal, Science, proposing the creation of the Global HIV Vaccine Enterprise. The authors recognized that current attempts to develop such a vaccine were insufficient in scale and focus, and that a renewed HIV vaccine research effort was required. The development of the Enterprise has gone through four phases as documented in our 2005 - 2007 report of activities: conceptualization (2003), planning (2004), initiation of activities (2005 – 2007), and implementation (2008 and beyond). The Enterprise model represents a new global way of thinking about scientific problems and approaches to resolving them through the formulation of a shared Scientific Strategic Plan. The plan is based on the identification of gaps and opportunities, the use of common tools, optimized resources, and iterative learning. Most importantly, it represents a new way for scientists to engage as a global community of problem-solvers, sharing materials and information, and balancing collaboration with healthy competition.

Where is Global HIV Vaccine Enterprise
Projects2Location of contracts awarded


Staff at Global HIV Vaccine Enterprise have experience in


  • hiv/aids
  • banking & finance budgeting
  • reproductive health
  • monitoring / evaluation
  • development


  • wellcome trust


  • united states
  • angola
  • jersey
  • nepal
  • burkina faso


  • managerial experience
  • business development
  • international experience
  • with experience in conflict areas

Contact Global HIV Vaccine Enterprise

Former staff

{{contact.full_name}} - {{contact.headline || contact.employment_title}}
  • Updated {{contact.updated_at | date:dateFormat}}
Company Offices
  • United States (headquarters)
  • New York
  • 125 Broad Street